Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Marie-Anne Damiette Smit"'
Autor:
Dwight H. Owen, Michael J. Giffin, Julie M. Bailis, Marie-Anne Damiette Smit, David P. Carbone, Kai He
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-8 (2019)
Abstract Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers. Despite high rates of response to first-line chemotherapy and radiotherapy, patients with extensive-stage disease eventually relapse, and very few patients sur
Externí odkaz:
https://doaj.org/article/efaf7cdb8770443ea93938d442098931
Autor:
Keegan Cooke, Jinghui Zhan, Juan Estrada, Marie-Anne Damiette Smit, Aditya Shetty, Jonathan Werner, Fei Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/0078139627a145c1bd49d4270db38425
Autor:
Hui Yang, Stephane Champiat, Ramaswamy Govindan, Ravi Salgia, Fiona Blackhall, Everett Vokes, Michael Boyer, Marie-Anne Damiette Smit, Melissa Johnson, Hossein Borghaei, Luis Paz-Ares Rodrigues, Rene Boosman, Horst-Dieter Hummel, W Victoria Lai, Hibiki Udagawa, Anne Chiang, Christine Hann, Mukul Minocha, Nooshin Hashemi-Sadraei, Aditya Shetty, Taofeek Owonikoko
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f2567de972aa4a01b4c2c02dfa5cecc2
Autor:
Albiruni RA Razak, James M Cleary, Michael Boyer, Emiliano Calvo Aller, William Edenfield, R Donald Harvey, Annemie Rutten, David P Ryan, Hansen Wong, Neelesh Soman, Marie-Anne Damiette Smit
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background To determine the safety and efficacy of the anti-colony-stimulating factor 1 receptor (anti-CSF1R) monoclonal antibody AMG 820 in combination with pembrolizumab in patients with select solid tumors.Patients and methods Patients had advance
Externí odkaz:
https://doaj.org/article/c86d4e961e1c408ea5c8168b4d7c83df
Autor:
Giffin Michael John, Marie-Anne Damiette Smit, Kai He, Dwight H. Owen, David P. Carbone, Julie M. Bailis
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-8 (2019)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Small cell lung cancer (SCLC) accounts for approximately 15% of all lung cancers. Despite high rates of response to first-line chemotherapy and radiotherapy, patients with extensive-stage disease eventually relapse, and very few patients survive more
Autor:
Paula Rodríguez-Otero, Anita D'Souza, Donna Ellen Reece, Niels W.C.J. van de Donk, Ajai Chari, Amrita Y. Krishnan, Thomas G. Martin, Maria-Victoria Mateos, Daniel Morillo, David Duane Hurd, Laura Rosiñol, Anna Sureda Balari, Ralph Wäsch, Deeksha Vishwamitra, Shun Xin Wang Lin, Thomas Prior, Lien Vandenberk, Marie-Anne Damiette Smit, Albert Oriol Rocafiguera, Bhagirathbhai R. Dholaria
Publikováno v:
Journal of Clinical Oncology. 40:8032-8032
8032 Background: Teclistamab (tec; JNJ-64007957) is a BCMA × CD3 T-cell redirecting bispecific antibody under investigation in patients (pts) with RRMM. Daratumumab (dara) is a CD38 mAb with direct on-tumor and immunomodulatory actions. Initial clin
Autor:
Luis Paz-Ares Rodrigues, Melissa Lynne Johnson, Fiona H Blackhall, Michael Boyer, Hossein Borghaei, Hibiki Udagawa, Christine L. Hann, Stéphane Champiat, W Victoria Lai, Anne C. Chiang, Rene J. Boosman, Nooshin Hashemi-Sadraei, Everett E. Vokes, Afshin Dowlati, Marie-Anne Damiette Smit, Ramaswamy Govindan, Taofeek K. Owonikoko, Horst-Dieter Hummel, Ravi Salgia, Hui Yang, Mukul Minocha, Aditya Shetty
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Delta-like ligand 3 (DLL3) is an inhibitory Notch ligand that is highly expressed in small cell lung cancer (SCLC) and minimally expressed in normal tissues.1 AMG 757, a half-life extended BiTE® immune therapy, binds to DLL3 on tumor cell
Autor:
Marie-Anne Damiette Smit, Manish A. Shah, Jeanne Tie, David P. Ryan, R. Donald Harvey, Victor Moreno, Dirk Jäger, Emilliano Calvo Aller, Neelesh Soman, James M. Cleary, William Jeffery Edenfield, Michael Boyer, Annemie Rutten, Gloria Juan, Kyriakos P. Papadopoulos, Erik Rasmussen, Dirk Nagorsen, Hansen Wong, Anthony J. Olszanski, Albiruni Ryan Abdul Razak, Nehal Lakhani
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundTo determine the safety and efficacy of the anti-colony-stimulating factor 1 receptor (anti-CSF1R) monoclonal antibody AMG 820 in combination with pembrolizumab in patients with select solid tumors.Patients and methodsPatients had advanced,
Autor:
R. Donald Harvey, Suanna S. Bruinooge, Dana Walker, Marie-Anne Damiette Smit, Atiqur Rahman, Caroline Schenkel, Michael A. Thompson, Stuart M. Lichtman, Patricia Cortazar, Nancy Roach, Louis Fehrenbacher
Publikováno v:
Journal of Clinical Oncology. 35:3753-3759
Purpose Patients with organ dysfunction, prior or concurrent malignancies, and comorbidities are often excluded from clinical trials. Excluding patients on the basis of these factors results in clinical trial participants who are healthier and younge
Autor:
Jinghui Zhan, Keegan Cooke, Paul E. Hughes, Marie-Anne Damiette Smit, Julie M. Bailis, Aditya Shetty, Jude Canon, Jonathan Werner, Juan Estrada
Publikováno v:
Journal of Thoracic Oncology. 16:S343-S344